Herein, we present a novel bioadhesive microcarriers delivery system encapsulated with interleukin‐27 (IL‐27) highly expressive MSC extracellular vehicles (EVs) to treat IBD through rectal administration, as schemed in Figure 1. Here, IL27 is linked to inflammatory bowel disease.